BTK and X-linked agammaglobulinemia: Since the first description of X-linked agammaglobulinemia (XLA, OMIM entry 300300) (1) and the identification of Bruton’s tyrosine kinase (BTK) as its genetic cause (2), BTK has been widely characterized as a critical mediator of B cell receptor (BCR) signaling and thus adaptive immunity (3).